PMH21- CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES ASSOCIATED WITH OLANZAPINE IN PATIENTS WITH BIPOLAR DISORDER AS COMPARED WITH HALOPERIDOL
Sep 1, 2001, 00:00
10.1016/S1098-3015(11)71630-8
https://www.valueinhealthjournal.com/article/S1098-3015(11)71630-8/fulltext
Title :
PMH21- CLINICAL AND HEALTH-RELATED QUALITY OF LIFE OUTCOMES ASSOCIATED WITH OLANZAPINE IN PATIENTS WITH BIPOLAR DISORDER AS COMPARED WITH HALOPERIDOL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71630-8&doi=10.1016/S1098-3015(11)71630-8
First page :
Section Title :
Open access? :
No
Section Order :
144